This was the stock's second consecutive day of gains.

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Readers hoping to buy Quest Diagnostics Incorporated (NYSE:DGX) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a new solution aimed at broadening access to human papillomavirus (HPV) screening to help identify women who ...

The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

Thrivent Financial for Lutherans decreased its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.1% ...

Quest Diagnostics Inc.’s DGX investments in Advanced Diagnostics are paying off, aiming to deliver and scale innovative services that improve patient care and drive growth. The company focuses ...

With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and ...

With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and services in the United States and internationally. It operates through two ...

The Company’s total aggregate Q1 2025 revenue of approximately $12.1 million (based on a BTC price of $83,500 as of March 31, 2025, per CoinMarketCap) represents an increase in quarterly revenue of ...